CN Patent

CN102596297B — 药物产品、干粉吸入器和多流碰撞器布置

Assigned to Merck Sharp and Dohme BV · Expires 2014-09-10 · 12y expired

What this patent protects

本发明涉及干粉吸入器和药物产品，更具体地，涉及用于使干粉分配器中的干粉发生解凝聚的多流碰撞器。各种实施例提供药物产品、干粉吸入器和多流碰撞器布置。本发明的各种实施例提供一种多流碰撞器，其利用碰撞的干粉流为干粉分配器提供期望的解凝聚能力。

USPTO Abstract

本发明涉及干粉吸入器和药物产品，更具体地，涉及用于使干粉分配器中的干粉发生解凝聚的多流碰撞器。各种实施例提供药物产品、干粉吸入器和多流碰撞器布置。本发明的各种实施例提供一种多流碰撞器，其利用碰撞的干粉流为干粉分配器提供期望的解凝聚能力。

Drugs covered by this patent

umeclidinium-bromide (UMECLIDINIUM BROMIDE)

Patent Metadata

Patent number: CN102596297B
Jurisdiction: CN
Classification: —
Expires: 2014-09-10
Drug substance claim: No
Drug product claim: No
Assignee: Merck Sharp and Dohme BV
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.